0

Bosutinib

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP380843754
CAS380843-75-4
Structure
MDL NumberMFCD07367846
Molecular Weight530.45
InChI KeyUBPYILGKFZZVDX-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: ≥15 mg/mL
Assay≥98% (HPLC)
Coloroff-white to light brown
Formpowder
Size5MG
Storage Conditionsroom temp
1

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial

Jorge E Cortes, Carlo Gambacorti-Passerini, Michael W Deininger, Michael J Mauro, Charles Chuah, Dong-Wook Kim, Irina Dyagil, Nataliia Glushko, Dragana Milojkovic, Philipp le Coutre, Valentin Garcia-Gutierrez, etc.

J Clin Oncol. 2018 Jan 20;36(3):231-237.

PMID: 29091516

1

Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial

Jorge E Cortes, Dong-Wook Kim, Hagop M Kantarjian, Tim H Brümmendorf, Irina Dyagil, Laimonas Griskevicius, Hemant Malhotra, Christine Powell, Karïn Gogat, Athena M Countouriotis, Carlo Gambacorti-Passerini

J Clin Oncol. 2012 Oct 1;30(28):3486-92.

PMID: 22949154

1

Chronic Myeloid Leukemia: 2018 Update on Diagnosis, Therapy and Monitoring

Elias Jabbour, Hagop Kantarjian

Am J Hematol. 2018 Mar;93(3):442-459.

PMID: 29411417

1

Drug Hepatotoxicity: Newer Agents

Chalermrat Bunchorntavakul, K Rajender Reddy

Clin Liver Dis. 2017 Feb;21(1):115-134.

PMID: 27842767

1

Tyrosine Kinase Inhibitors Available for Chronic Myeloid Leukemia: Efficacy and Safety

Valentín García-Gutiérrez, Juan Carlos Hernández-Boluda

Front Oncol. 2019 Jul 3;9:603.

PMID: 31334123

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode